Incidence Rates and Time Trends of Skin Cancer in Golestan Province, Northeastern Iran, 2005-2018
Open Access
- 15 May 2024
- journal article
- research article
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 27 (6) , 289-297
Abstract
Background: Given the significant occurrence of skin cancer in the Middle East and the existing research gap concerning its incidence and trends, this research aimed to study the epidemiology and trend changes of skin cancer in the Golestan province, Northeastern Iran. Methods: The Golestan Population-based Cancer Registry’s (GPCR’s) data bank was utilized to gather information on confirmed skin cancer cases in the province during 2005–2018. We used Poisson regression analysis for comparing incidence rates between groups. P values less than 0.05 were considered statistically significant. Results: Of 1690 patients (mean age: 62.05±15.83 years), most were male (60.1%) and resided in urban areas (61.5%). The agestandardized rate (ASR) of non-melanoma and melanoma skin cancer was 8.49 and 0.56 per 100000 persons-year, respectively. A notably higher ASR for non-melanoma skin cancer (NMSC) was observed in men (ASR: 10.60; 95% CI: 9.91-11.29) (P<0.01) and urban residents (ASR: 10.19; 95% CI: 9.52-10.82) (P<0.01). There was no significant difference in the ASR of melanoma skin cancer based on gender (P=0.24) and place of residence (P=0.48). The incidence trend of melanoma (estimated annual percent change [EAPC]: -3.28; 95% CI: -18.54 to 14.83) and NMSC (EAPC: 0.39; 95% CI: -3.99 to 4.97) did not differ significantly. Conclusion: During the 14-year study period, the ASR of both types of skin cancer exhibited a consistent pattern, except for NMSC, which showed higher rates among men and urban residents. This should be taken into consideration when formulating preventive and control strategies in the study area.Keywords
This publication has 31 references indexed in Scilit:
- Trends of non-melanoma skin cancer incidence in Hong Kong and projection up to 2030 based on changing demographicsAnnals of Medicine, 2022
- Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019Cancer Medicine, 2021
- The Impact of Human Papillomavirus Infection on Skin Cancer: A Population-Based Cohort StudyThe Oncologist, 2020
- Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in GermanyJournal of Investigative Dermatology, 2017
- Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell CarcinomaMayo Clinic Proceedings, 2017
- Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: A population-based studyCancer Epidemiology, 2016
- Prevalence and Costs of Skin Cancer Treatment in the U.S., 2002−2006 and 2007−2011American Journal of Preventive Medicine, 2015
- Risk of Several Cancers is Higher in Urban Areas after Adjusting for Socioeconomic Status. Results from a Two-Country Population-Based Study of 18 Common CancersJournal of Urban Health, 2014
- Non-Melanoma Skin Cancer Incidence and Impact of Skin Cancer Screening on IncidenceJournal of Investigative Dermatology, 2014
- Skin Cancer: An Overview of Epidemiology and Risk FactorsSeminars in Oncology Nursing, 2013